User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 1 - 25 of 26 results.

Pages

    • Speech
    Companion diagnostics: Clinical significance of Pharmacogenetics, the concept of personalized therapy
    Elens, Laure[UCL] (2013) xSample Luminex Congress — Rotterdam, The Netherlands
    • Speech
    Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: Towards updated genotype-based dosing guidelines
    Elens, Laure[UCL] (2013) 13th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) — Salt Lake City, USA
    • Speech
    Early Tacrolimus Dosing in Pediatric Liver Transplantation Depends on Recipient CYP3A5 and ABCB1 (or MDR1) Genotypes: Experience in Living Donor Recipients
    Elens, Laure[UCL] (2013) 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology — Salt lake city, USA
    • Speech
    Impact of POR*28 on the Pharmacokinetics of Tacrolimus and Cyclosporine A in Renal Transplant Patients
    Elens, Laure[UCL] (2013) 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology — Salt lake city usa
    • Speech
    A pharmacogenetic model predicting low paclitaxel clearance based on the DMET platform.
    Elens, Laure[UCL] (2013) Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) — Chicago, USA
    • Speech
    Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin
    Elens, Laure[UCL] (2013) 13th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) — Salt Lake city, USA
    • Speech
    Pharmacogenetics of statins: Are we ready for the clinic?
    Elens, Laure[UCL] (2013) the Royal Belgian Society of Clinical Chemistry annual symposium — Brussels, Belgium
    • Speech
    Impact of POR*28 on the Clinical Pharmacokinetics of CYP3A Phenotyping Probes Midazolam and Erythromycin
    Elens, Laure[UCL] (2013) 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology — Salt Lake City, USA
    • Speech
    Genetic Variation in the PPARA Gene Is Associated with Simvastatin-Mediated Cholesterol Reduction in the Rotterdam Study
    Elens, Laure[UCL] (2013) 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management — Montréal, Canada

Pages